Table 3.

Results in domains showing the greatest differences between AD patients and VaD subtypes.

VaD Subtype	Domain	k	n	${\beta }_g$ [95% ETI]	Bayes factor	${\tau }_{Study}$	Newcastle-Ottawa scale
							S	C	E
VaD	Digit span backwards S, E,	7	225	0.33 [0.12, 0.52]	9.38	0.05	3	1	1
	Delayed recall: Word list S, E	4	235	−0.61 [−0.97, −0.26]	22.71	0.18	3	0	1
	Wechsler memory scale verbal recognition	2	85	−1.12 [−1.75, 0.04]	4.72	0.42	3	1	1
	CERAD: Word list recognition	4	228	−0.92 [−1.38, −0.43]	19.21	0.27	3	1	1
	Other measures of visual memoryS: Delayed recall	5	177	−0.85 [−1.29, −0.32]	13.67	0.18	3	1	1
	Immediate visual associative memory	4	354	−1.01 [−1.49, −0.43]	20.02	0.25	3	1	1
sVaD	Phonemic fluency S, E, A, G	17	1,460	0.51 [0.22, 0.77]	42.36	0.40	3	1	1
	Basic ADLS, E, A, G	3	290	−1.73 [−3.63, 0.01]	4.14	1.92	3	0	1
	Graphical sequence test	2	152	0.82 [0.02, 1.47]	3.11	0.36	3	0	1
	Delayed recall: Prose	4	670	−0.70 [−1.12, −0.27]	13.11	0.30	3	1	1
	Delayed recall: Word list S, E	7	805	−0.64 [−0.88, −0.36]	72.97	0.18	3	1	1
	Discriminability in verbal memory	4	489	−0.76 [−1.26, −0.26]	11.50	0.28	3	0	1

Positive effect sizes denote better performance of AD groups and are marked in bold. VaD, Vascular dementia; sVaD, Subcortical vascular dementia. Domain superscripts denote moderators included in the analyses: differences in average dementia severity (S), years of education (E), age (A) and proportion of women (G). k, Number of studies; n, Number of patients; 95% ETI, 95% equal-tailed credible interval. Newcastle-Ottawa-Scale Subscales medians: Selection (S), Comparability (C), Exposure (E). ADL, Activities of daily living. ${\tau }_{\mathrm{Study}},$ Standard deviation of random effects between studies. CERAD, Consortium to Establish a Registry for Alzheimer’s disease Test Battery.